HDAC1 antibody
Quick Overview for HDAC1 antibody (ABIN6952380)
Target
See all HDAC1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Specificity
- Polyclonal antibody raised in rabbit against the C-terminal region of human HDAC1 (Histone deacetylase 1), using a KLH-conjugated synthetic peptide.
-
Cross-Reactivity
- Mouse (Murine)
-
Purification
- Peptide affinity purified
-
Immunogen
- synthetic peptide
-
-
-
-
Application Notes
-
ChIP/ChIP-seq 2 μg:ChIP
ELISA 1:4,000
WB 1:1,000
Protein array 1:100,000
IF 1:500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.73 μg/μL
-
Buffer
- PBS, 0.05 % azide, 0.05 % ProClin300
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- HDAC1 (Histone Deacetylase 1 (HDAC1))
-
Alternative Name
- HDAC1
-
Background
- HDAC1 (UniProt/Swiss-Prot entry Q13547) catalyses the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Acetylation and deacetylation of these highly conserved lysine residues is important for the control of gene expression and HDAC activity is often associated with gene repression. Histone deacetylation is established by the formation of large multiprotein complexes. HDAC1 also interacts with the retinoblastoma tumor suppressor protein and is able to deacetylate p53. Therefore, it also plays an essential role in cell proliferation and differentiation and in apoptosis.
-
UniProt
- Q13547
-
Pathways
- Neurotrophin Signaling Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Mitotic G1-G1/S Phases, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Negative Regulation of intrinsic apoptotic Signaling, Embryonic Body Morphogenesis
Target
-